Clinical Trial Update: Neuroinflammation and Modulating Factors in Depression and HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating neuroinflammation and modulating factors in depression and HIV has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Major Depressive Disorder

Snippet

Sponsor: University of Minnesota | Conditions: Depression, HIV | Phase 2 | Status: COMPLETED | Results posted: 2025-01-09